Fermentation,
Год журнала:
2024,
Номер
10(10), С. 518 - 518
Опубликована: Окт. 12, 2024
Aims:
Research
on
probiotics
for
constipation
management
is
still
growing,
and
plays
a
crucial
role
in
the
definition
of
strategy
bowel
wellbeing,
constipation,
related
outcomes.
The
present
systematic
review
meta-analysis
beneficial
effects
SYNBIO®
blend,
to
consolidate
data
from
various
clinical
trials,
was
conducted.
Methods:
A
literature
search
using
PubMed,
Web
Science,
Google
Scholar
databases
limited
trials
that
used
either
as
dietary
supplements
or
probiotic-enriched
foods.
Independently,
two
reviewers
evaluated
trial’s
quality
extracted
all
data.
95%
confidence
interval
(CI)
weighted
mean
difference
(MD)
pool
continuous
For
analysis,
Review
Manager
version
5.4
used.
Results:
Seven
involving
total
1095
subjects
were
included
analysis.
Overall,
blend
significantly
improved
relief
by
0.75
(95%
CI:
0.31
1.19;
p
=
0.0008)
52%
subjects,
increased
intestinal
regularity
1.90
compared
placebo
1.02
2.78;
<
0.0001)
more
than
60%
individuals.
No
adverse
events
reported.
Conclusions:
found
improve
overall
regularity,
abdominal
pain,
cramping.
This
suggests
people
with
these
specific
symptoms
could
benefit
this
probiotic
combination.
Food & Function,
Год журнала:
2024,
Номер
15(11), С. 6118 - 6133
Опубликована: Янв. 1, 2024
Bifidobacterium
longum
S3
influenced
the
intestinal
barrier
and
immunity,
water
channel
protein
expression,
neurotransmitter
GI
active
peptide
levels
by
affecting
immunity
modulating
changes
in
of
fatty
acid
metabolites,
especially
LCFAs.
Nutrients,
Год журнала:
2023,
Номер
15(19), С. 4230 - 4230
Опубликована: Сен. 30, 2023
Constipation
is
currently
one
of
the
most
common
gastrointestinal
disorders,
and
its
causes
are
diverse.
Multi-strain
probiotics
often
considered
a
more
effective
treatment
than
single-strain
probiotics.
In
this
study,
constipation
model
was
constructed
using
loperamide
hydrochloride
to
evaluate
ability
multi-strain
probiotic
combination
four
different
ratios
Bifidobacterium
Lactobacillus
regulate
intestinal
flora,
relieve
constipation,
explore
initial
mechanism
in
mice.
After
weeks
intervention,
BM1,
BM2,
PB2
effectively
relieved
constipation;
however,
pathways
involved
were
different.
The
Bifidobacteria-dominated
formulations
BM1
BM2
mainly
changed
composition
structure
flora
significantly
decreased
relative
abundance
Tyzzerella,
Enterorhabdus,
Faecalibaculum,
Gordonibacter,
Mucispirillum
stool;
increased
Parabacteroides
content
short-chain
fatty
acids
(SCFAs)
restored
motilin
(MTL)
vasoactive
peptide
(VIP)
levels;
downregulated
interleukin
6
(IL-6)
IL-8
levels
serum.
This
repaired
inflammatory
response
caused
by
constipation.
Finally,
it
promoted
peristalsis
tract,
increasing
stool
water
content,
relieving
While
Lactobacillus-dominated
formula
serum
neurotransmitters
(MTL,
SP
(substance
P),
VIP
PYY
(Peptide
YY))
factors
(IL-1,
IL-6
IL-8),
Gordonibacter
then
acetic
acid
thereby
reducing
level
inflammation
changing
properties
motility.
Probiotics and Antimicrobial Proteins,
Год журнала:
2024,
Номер
unknown
Опубликована: Март 12, 2024
Abstract
Diarrhea,
a
common
gastrointestinal
symptom
in
health
problems,
is
highly
associated
with
gut
dysbiosis.
The
purpose
of
this
study
to
demonstrate
the
effect
multistrain
probiotics
(Sensi-Biome)
on
diarrhea
from
perspective
microbiome-neuron
axis.
Sensi-Biome
(
Lactiplantibacillus
plantarum
,
Bifidobacterium
animalis
subsp.
lactis
Lactobacillus
acidophilus
Streptococcus
thermophilus
bifidum
and
Lactococcus
)
was
administered
4%
acetic
acid–induced
rat
model
at
concentrations
1
×
10
8
(G1),
9
(G2),
CFU/0.5
mL
(G3).
Diarrhea-related
parameters,
inflammation-related
cytokines,
stool
microbiota
analysis
by
16S
rRNA
were
evaluated.
A
targeted
untargeted
metabolomics
approach
used
analyze
cecum
samples
using
liquid
chromatography
orbitrap
mass
spectrometry.
moisture
content
p
<
0.001),
intestinal
movement
rate
0.05),
pH
0.05)
significantly
recovered
G3.
Serotonin
levels
decreased
groups.
inflammatory
serotonin,
tryptophan
hydroxylase
expression
improved
At
phylum
level,
showed
highest
relative
abundance
Firmicutes
.
Short-chain
fatty
acids
including
butyrate,
iso-butyrate,
propionate,
iso-valeric
acid
modified
Equol
oleamide
In
conclusion,
effectively
controls
modulating
metabolites
serotonin
pathway.
Current Research in Microbial Sciences,
Год журнала:
2025,
Номер
8, С. 100340 - 100340
Опубликована: Янв. 1, 2025
Antiretroviral
therapy
(ART)
effectively
reduces
opportunistic
infections
and
mortality
in
people
living
with
HIV
(PLWH);
however,
some
patients
exhibit
poor
immune
recovery.
This
study
explores
the
connections
among
responses,
metabolites,
gut
microbiota
PLWH
differing
reactions
to
ART.
We
analyzed
composition,
markers
38
who
showed
an
immunological
response
(IR)
32
did
not
(INR),
as
classified
according
CD4+
T-cell
levels
after
24
months
of
Additionally,
vitro
assays
using
cell
counting
kit
8,
flow
cytometry,
quantitative
real-time
reverse
transcription
PCR
were
employed
assess
effects
metabolites
on
viability,
marker
expression,
cytokine
levels.
Gut
metabolic
profiles
differed
significantly
between
IR
INR
groups.
Enterococcus
was
more
abundant
group,
whereas
[Ruminococcus]_gnavus_group
reduced.
Significant
pathway
alterations
included
decreased
folate
biosynthesis
biotin
metabolism.
observed
negative
associations
Parabacteroides
activation
T-cells,
positive
correlations
CD4/CD8
ratios.
inverse
relationships
these
markers.
Indole-3-acetyl-beta-1-D-glucoside
(area
under
curve
value
=
0.8931),
had
best
discriminatory
ability.
Further
experiments
that
proportions
CD4+CD57+,
effector
CD4+,
CD4+PD1+,
CD8+CD57+,
CD8+,
CD8+HLA-DR+
T
cells.
Moreover,
mRNA
expression
analysis
treatment
led
a
suppression
pro-inflammatory
cytokines.
The
multi-omics
approach
highlighted
potential
biomarkers
for
recovery
HIV,
suggesting
avenues
further
research
into
strategies.
World Journal of Gastroenterology,
Год журнала:
2025,
Номер
31(9)
Опубликована: Фев. 18, 2025
Runchangningshen
paste
(RCNSP)
is
a
made
of
four
medicinal
and
edible
homologous
Chinese
medicine
mixed
with
honey.
It
known
for
its
ability
to
nourish
yin
blood
as
well
loosen
the
bowel
relieve
constipation.
The
pathophysiology
functional
constipation
(FC)
associated
reduction
in
mucin-2
(MUC2)
secretion
microbial
dysbiosis.
To
investigate
underlying
mechanism
RCNSP
against
FC
through
MUC2
gut
mucosal
microbiota.
Ultra-performance
liquid
chromatography
tandem
mass
spectrometry
characterized
composition
elucidate
material
basis
action.
model
was
induced
via
loperamide
gavage
(16
mg/kg)
twice
daily
7
days.
Applying
defecation
function
gastrointestinal
motility
assess
severity.
Hematoxylin
eosin
Alcian
blue-periodic
acid-schiff
staining
analyzed
colonic
morphology.
Transmission
electron
microscope
used
observe
ultrastructure
goblet
cells
(GCs).
Immunofluorescence
colocalization,
quantitative
PCR,
western
blot
assessed
impact
on
gene
protein
expression
within
NLRP6/autophagy
pathway.
16S
rDNA
employed
sequence
contained
12
components
potential
laxative
effects.
enhanced
function,
accelerated
motility,
maintained
integrity.
treatment
significantly
increased
GC
abundance
production
while
preserving
ultrastructure.
At
molecular
level,
colocalized
key
regulatory
proteins
modulated
mRNA
expressions
Through
sequencing
analysis,
altered
microbiota
composition.
Specifically,
it
beneficial
bacterial
strains
reducing
harmful
ones.
Simultaneously,
reduced
butyrate-producing
bacteria
like
Proteobacteria,
Enterobacteriaceae,
Blautia,
Eubacterium
decreased
hydrogen
sulfide-producing
species,
such
Prevotellaceae.
also
bile
acid-inhibiting
g_Eubacter_coprostanoligenes_group
Erysipelotrichaceae
increasing
acid-producing
Colidextribacter.
Our
findings
suggested
that
ameliorated
dual
mechanism:
stimulated
by
activating
NLRP6
inflammasome-mediated
autophagy
International Journal of General Medicine,
Год журнала:
2025,
Номер
Volume 18, С. 1007 - 1022
Опубликована: Фев. 1, 2025
To
explore
the
mechanism
of
Zhuyang
Tongbian
Decoction
(ZTD)
in
treating
functional
constipation
(FC)
by
observing
its
effects
on
intestinal
flora
composition,
metabolic
function
gut
microbiota,
fecal
short-chain
fatty
acid
(SCFA)
levels,
and
serum
concentrations
TLR4,
NF-κB,
TNF-α,
IL-6
patients
with
FC.
40
FC
were
randomly
divided
into
control
group
treatment
group,
20
cases
each
group.
And
healthy
volunteers
recruited
during
same
period.
The
was
administered
lactulose,
while
treated
ZTD.
16s
RNA
sequencing
technology
used
to
compare
changes
structure
diversity
before
after
treatment.
Changes
levels
SCFAs
faeces
TNF-α
analysed.
Metagenomics
assessed
microbiota
functions.
showed
a
significant
increase
relative
abundance
beneficial
bacteria,
including
Bifidobacterium,
Lactobacillus,
Faecalibacterium_prausnitzii
(P
<
0.05),
whereas
Desulfobacterota
Ruminococcus
significantly
reduced
0.05).
Notably,
acetic
propionic
higher
Serum
biomarkers
decreased
that
Carbohydrate
metabolism,
Metabolism
cofactors
vitamins,
C5-
Branched
dibasic
metabolism
increased
ZTD
notably
improves
composition
function,
regulates
SCFA
reduces
inflammation
markers
patients.
strain
shows
potential
regulation
may
play
crucial
role
efficacy
for
Frontiers in Microbiology,
Год журнала:
2023,
Номер
14
Опубликована: Окт. 31, 2023
Tuberculosis
is
a
chronic
infectious
disease
caused
by
Mycobacterium
tuberculosis
(MTB)
that
remains
significant
global
health
challenge.
The
extensive
use
of
antibiotics
in
treatment,
disrupts
the
delicate
balance
microbiota
various
organs,
including
gastrointestinal
and
respiratory
systems.
This
gut-lung
axis
involves
dynamic
interactions
among
immune
cells,
microbiota,
signaling
molecules
from
both
organs.
alterations
microbiome
resulting
anti-TB
treatment
can
significantly
influence
course
tuberculosis,
impacting
aspects
such
as
complete
healing,
reinfection,
relapse.
review
aims
to
provide
comprehensive
understanding
context
with
specific
focus
on
impact
microbiome.
Molecules,
Год журнала:
2023,
Номер
28(23), С. 7766 - 7766
Опубликована: Ноя. 24, 2023
Opioid
receptor
agonists,
particularly
those
that
activate
µ-opioid
receptors
(MORs),
are
essential
analgesic
agents
for
acute
or
chronic
mild
to
severe
pain
treatment.
However,
their
use
has
raised
concerns
including,
among
others,
intestinal
dysbiosis.
In
addition,
growing
data
on
constipation-evoked
dysbiosis
have
been
reported.
Opioid-induced
constipation
(OIC)
creates
an
obstacle
continuing
treatment
with
opioid
analgesics.
When
non-opioid
therapies
fail
overcome
the
OIC,
antagonists
peripheral,
fast
first-pass
metabolism,
and
gastrointestinal
localized
effects
remain
drug
of
choice
which
discussed
here.
At
first
glance,
seems
only
be
restricted
constipation,
however,
recent
OIC-related
its
contribution
appearance
several
side
garnered
a
great
attention
from
researchers.
Peripheral
MORs
also
considered
as
future
target
analgesics
limited
central
effects.
The
properties
MOR
counteracting
influence
possibly
peripheral
MOR-mediated
antinociception,
will
highlighted.
A
new
concept
is
proposed
developing
gut-selective
treat
restore
OIC
while
keeping
antinociception
unaffected.
impact
in
relation
changes
gut
microbiome
included.
Frontiers in Nutrition,
Год журнала:
2024,
Номер
11
Опубликована: Фев. 16, 2024
Personalized
probiotic
regimens,
taking
into
account
individual
characteristics
such
as
stool
patterns,
have
the
potential
to
alleviate
gastrointestinal
disorders
and
improve
gut
health
while
avoiding
variability
exhibited
among
individuals
by
conventional
probiotics.
This
study
aimed
explore
efficacy
of
personalized
interventions
in
managing
distinct
patterns
(constipation
diarrhea)
investigating
their
impact
on
microbiome
symptoms
using
a
prospective,
randomized,
double-blind,
placebo-controlled
clinical
trial
design.
research
leverages
multi-strain
formulas,
Consti-Biome
Sensi-Biome,
which
previously
demonstrated
alleviating
constipation
diarrhea
symptoms,
respectively.
Improvement
improvement
compositional
changes
were
analyzed
participants
with
predominant
or
symptoms.
Results
indicate
that
tailored
probiotics
could
promoting